… The spread of extended-spectrum β-lactamase (ESBL) genes in Enterobacteriaceae such …
ESBL producers might be susceptible to β-lactam-β-lactamase inhibitor (BLBLI) combination …

… are inhibited by β-lactamase inhibitors [1–3]. Although hyperproduction of β-lactamases or
… the activity of these compounds, β-lactam/β-lactam inhibitor combinations (BLBLI) such as …

… We investigated whether β-lactam/β-lactamase inhibitor (BLBLI) combinations are as
effective as carbapenems in the treatment of bloodstream infections (BSI) due to ESBL-E. A …

… or to β-lactam-β-lactamase inhibitor combinations during hospitalization is a risk factor for
ESBL-producing Klebsiella infections, while broad-spectrum cephalosporins are predictive of …

… colleagues asserts that the β-lactam/β-lactamase inhibitor (BLBLI) combinations piperacillin/…
due to Escherichia coli possessing extended-spectrum β-lactamases (ESBLs). The authors …

… in combination with the β-lactamase inhibitors covered in this review. The first generation
of β-lactamase inhibitors … Their findings reveal a broad spectrum synergistic effect against …

Objective To study the bactericidal activity of β-lactam antibiotics (imipenem, cefepime,
cefpirome) alone or in combination with a β-lactamase inhibitor (sulbactam) in the presence or …

… series of broad-spectrum β-lactamases on susceptibility to … the potential effect broad-spectrum
β-lactamases might have … of the different broad-spectrum β-lactamases on resistance to BL/…

… β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum
β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. …

… are new β-lactamase inhibitors that are being studied in combination with β-lactams. Clinical
and … β-Lactam antibiotics are a mainstay for the treatment of many infections. The addition of …